Medpace Holdings, Inc. (MEDP)
Health Care ยท Services-Commercial Physical & Biological Research
Medpace Holdings, Inc. (MEDP) is listed on Nasdaq, where its shares have traded since August 11, 2016. SentiSense covers Medpace Holdings, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Commercial Physical & Biological Research. August J. Troendle is its chief executive officer. The company reports 6,600 employees, and its corporate website is www.medpace.com.
About Medpace Holdings, Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Latest reported results
Medpace Holdings, Inc. reported revenue of $716.0 million for Q3 FY2026, up 8.5% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 679 institutions reported holding MEDP, with 24.5 million shares worth $13.0 billion in aggregate. The largest reported holders were BlackRock, Vanguard and T. Rowe Price. Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter.
More on MEDP
- MEDP sentiment: whether news and social coverage of Medpace Holdings, Inc. leans bullish or bearish, and the stories driving it.
- MEDP ownership: all 679 reporting institutions, plus insider and congressional trades.
- MEDP financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
Frequently asked questions
What does Medpace Holdings, Inc. do?
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms.
What sector is MEDP in?
SentiSense classifies Medpace Holdings, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Commercial Physical & Biological Research.
Where does MEDP stock trade?
Medpace Holdings, Inc. (MEDP) is listed on Nasdaq, where its shares have traded since August 11, 2016.
Who is the CEO of Medpace Holdings, Inc.?
August J. Troendle is the chief executive officer of Medpace Holdings, Inc..